Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

WESTMINSTER, Colo.--(BUSINESS WIRE)--Vantor, the leading provider of unified spatial intelligence from space to ground, has been awarded its third National Geospatial-Intelligence Agency (NGA) Luno contract to provide NGA and other U.S. Government agencies automated, near real-time orbital intelligence of high-interest objects in space. Under the $2.3 million contract, Vantor will utilize its high-resolution imagery of space objects, also known as non-Earth Imagery (NEI), to deliver intelligenc...

LONDON--(BUSINESS WIRE)--Collinson Insurance, the specialist travel and parametric insurance provider and part of the Collinson Group, has partnered with leading Spanish travel insurance broker Bujaldon to deliver a transformative claims operating model in Spain. Under the agreement, Collinson Insurance will give Bujaldon greater ownership and control over its claims service delivery, reducing resolution times from weeks to around 3 days. The new strategic partnership with Bujaldon is set to tr...

LONDRES--(BUSINESS WIRE)--Collinson Insurance, especialista en seguros de viaje y soluciones paramétricas y parte del grupo Collinson, ha firmado un acuerdo con Bujaldon, reconocido bróker español de seguros de viaje, para implantar en España un modelo de gestión de siniestros más eficiente. En virtud de este acuerdo, Collinson Insurance permitirá a Bujaldon asumir un mayor control en la gestión de los siniestros, lo que reducirá los plazos de resolución de varias semanas a unos tres días. Esta...

LONDON--(BUSINESS WIRE)--Project management professionals are rapidly embedding artificial intelligence (AI) into their day-to-day work, transforming how projects are planned, delivered and managed, according to new research from the Association for Project Management (APM), conducted in partnership with Censuswide. The survey of 1,000 project professionals in the UK highlights widespread adoption of AI tools across sectors including financial services, technology, construction, engineering and...

CAMBRIDGE, England--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,” said Thomas Fuchs, CEO, Mosaic Thera...

LONDON--(BUSINESS WIRE)--  1 April 2026 Next 15 Group plc Total Voting Rights Next 15 Group plc (the 'Company') announces that, as at 31 March 2026, the Company’s issued share capital consisted of 101,028,935 ordinary shares of 2.5p each (“Ordinary Shares”). No Ordinary Shares are held in treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, t...

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, announced that the Company has granted LG Chem, Ltd. ("LG Chem"), a leading global company headquartered in South Korea that specializes in life sciences as one of its core businesses, an exclusive worldwide license to develop and commercialize F...

DENVER--(BUSINESS WIRE)--Barrell hits 52,000 acres in Smackover Lithium Play and closes oversubscribed Series B investment. Plans to seek an operating partner in Q3 2026....